https://www.selleckchem.com/pr....oducts/camostat-mesi
For invasive breast cancer, sentinel node biopsy (SN is an acceptable alternative to axillary node clearance (ANC), although in the recent era, its role is under review.In ductal carcinoma in situ (DCIS), the benefit of SNB is even less well defined.Despite this, guidelines still recommend that it is performed in selected cases of DCIS.The aim of our study was to evaluate the diagnostic value of performing SNB in DCIS. Patients with a diagnosis of DCIS who underwent axillary staging with SNB between 2008-2019 in our
Like
Comment
Share
